Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID).
- Disclosed ownership: 5.1%.
- Date of event: 02 Jan 2026.
Point72 Asset Management, L.P. - 02 Jan 2026 SCHEDULE 13G Report for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- OVID
- Shares outstanding
- 131,906,059 shares
- Disclosed Ownership
- 6,727,209 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Jan 2026, 16:12:39 UTC
- Date of event
- 02 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5.1% ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID) on 02 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Jan 2026, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5.1% | 6,727,209 | 0 | 6,727,209 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5.1% | 6,727,209 | 0 | 6,727,209 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.1% | 6,727,209 | 0 | 6,727,209 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |